Previous 10 | Next 10 |
home / stock / mkgaf / mkgaf news
Merck Korea, a unit of Germany-based Merck KGaA (OTCPK:MKGAF) (OTCPK:MKKGY), signed an agreement with Seoul-based Standigm for artificial intelligence (AI) based drug discovery research. Under the Memorandum of Understanding (MOU), Standigm will accelerate its drug discove...
Merck KGaA's (OTCPK:MKGAF) (OTCPK:MKKGY) will spend ~€440M to expand its membrane and filtration manufacturing capabilities in Ireland. The German company said the investment, which is the largest in a single site ever for Merck’s Life Science business sector, is to in...
Merck KGaA (MKGAF) Q1 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Constantin Fest - Head of Investor Relations Belén Garijo - CEO of the Group Marcus Kuhnert - CFO Matthias Heinzel - CEO of Life Science Peter Guenter - CEO of Healthcare Kai Beckmann - CEO f...
The following slide deck was published by MERCK Kommanditgesellschaft auf Aktien in conjunction with their 2022 Q1 earnings call. For further details see: MERCK Kommanditgesellschaft auf Aktien 2022 Q1 - Results - Earnings Call Presentation
MERCK Kommanditgesellschaft auf Aktien press release (OTCPK:MKGAF): Q1 Non-GAAP EPS of €2.41. Revenue of €5.2B (+12.3% Y/Y). Organic sales growth (7.8%) supported by positive foreign exchange effects (4.4%) and a negligible acquisition-related sales increase (0.1%). Group EBITDA...
Merck KGaA's (OTCPK:MKGAF) (OTCPK:MKKGY) Q1 revenue grew driven by its Life Science segment and the company provided outlook for FY22. Q1 GAAP EPS rose +10.6% Y/Y to €2.41, while Net sales grew 12.2% Y/Y to ~€5.2B. EBITDA pre increased +7.8% to € 1.63B. "The out...
Nektar Therapeutics (NASDAQ:NKTR) will implement a cost restructuring plan so that it can focus on its two mid-stage pipeline assets that will result in the loss of 70% of its employees. The company said the plan will extend its cash runway into 1H 2025. After accounting for wind-down an...
As Danaher (DHR) is set to kick off the earnings season of the makers of Life Sciences & Diagnostic Tools on Thursday, Bank of America analysts led by Derik de Bruin issued cautious views on the subsector, citing macro and geopolitical headwinds. The earnings season for the group com...
MERCK Kommanditgesellschaft auf Aktien (MKGAF) Q4 2021 Earnings Conference Call March 3, 2022 08:00 AM ET Company Participants Constantin Fest - Head of Investor Relations Belén Garijo - Chair of the Executive Board and CEO Marcus Kuhnert - Member of the Executive Board, Chief Financial ...
The following slide deck was published by MERCK Kommanditgesellschaft auf Aktien in conjunction with their 2021 Q4 earnings call. For further details see: MERCK Kommanditgesellschaft auf Aktien 2021 Q4 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Merck Kgaa Company Name:
MKGAF Stock Symbol:
OTCMKTS Market:
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...